The role of obesity in laminitis is unclear, but as insulin concentrations correlate positively with obesity [28–30], weight loss as a secondary benefit of SGLT-2 inhibition could be desirable in certain cases. This evidence concerns the gene SLC5A2 and obesity disorder.